🔎 Trials Near Me

Home › Clear-cell metastatic renal cell carcinoma › Florida

Pag-aaral pangklinika para sa Clear-cell metastatic renal cell carcinoma sa Florida

5 pag-aaral para sa Clear-cell metastatic renal cell carcinoma ang naghahanap ng mga kalahok sa mga site sa Florida.

Mga Lungsod sa Florida

Opisyal na teksto ng pag-aaral (English)

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

  • NEO-811 Florida Site, Miami
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07300241

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

  • Research Site, Jacksonville
  • Research Site, Miami
  • Research Site, Orlando
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07011719

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

  • Mayo Clinic Pharmacy, Jacksonville
  • Orlando Health Ambulatory Care Center, Orlando
  • Orlando Health Cancer Institute, Orlando
  • at 1 pa
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07227415

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

  • Mayo Clinic in Florida, Jacksonville
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 12, 2026 · NCT06349642

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

  • AdventHealth Altamonte, Altamonte Springs
  • AdventHealth Celebration, Celebration
  • AdventHealth Kissimmee, Kissimmee
  • at 5 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2025 · NCT04510597

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.